118 related articles for article (PubMed ID: 28847747)
1. Hypoxia induced phosphorylation of estrogen receptor at serine 118 in the absence of ligand.
Park J; Lee Y
J Steroid Biochem Mol Biol; 2017 Nov; 174():146-152. PubMed ID: 28847747
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
Chen D; Washbrook E; Sarwar N; Bates GJ; Pace PE; Thirunuvakkarasu V; Taylor J; Epstein RJ; Fuller-Pace FV; Egly JM; Coombes RC; Ali S
Oncogene; 2002 Jul; 21(32):4921-31. PubMed ID: 12118371
[TBL] [Abstract][Full Text] [Related]
4. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.
Cheng J; Zhang C; Shapiro DJ
Endocrinology; 2007 Oct; 148(10):4634-41. PubMed ID: 17615152
[TBL] [Abstract][Full Text] [Related]
5. Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.
Huderson BP; Duplessis TT; Williams CC; Seger HC; Marsden CG; Pouey KJ; Hill SM; Rowan BG
Endocrinology; 2012 Sep; 153(9):4144-59. PubMed ID: 22733972
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
Duplessis TT; Williams CC; Hill SM; Rowan BG
Endocrinology; 2011 Jun; 152(6):2517-26. PubMed ID: 21505052
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic activation of unoccupied estrogen-receptor-alpha is mediated by hypoxia-inducible factor-1 alpha.
Cho J; Bahn JJ; Park M; Ahn W; Lee YJ
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):18-23. PubMed ID: 16797973
[TBL] [Abstract][Full Text] [Related]
9. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
10. Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer.
Yamashita H; Nishio M; Toyama T; Sugiura H; Kondo N; Kobayashi S; Fujii Y; Iwase H
Endocr Relat Cancer; 2008 Sep; 15(3):755-63. PubMed ID: 18550720
[TBL] [Abstract][Full Text] [Related]
11. Elevated phosphorylation of estrogen receptor α at serine-118 in ovarian endometrioma.
Sun H; Hirata T; Koga K; Arakawa T; Nagashima N; Neriishi K; Elsherbini M; Maki E; Izumi G; Harada M; Hirota Y; Wada-Hiraike O; Osuga Y
F S Sci; 2022 Nov; 3(4):401-409. PubMed ID: 35654737
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibiting the proteasomal degradation of estrogen receptor alpha on estrogen receptor alpha activation under hypoxic conditions.
Park YM; Cho JY; Koo YD; Lee YJ
Biol Pharm Bull; 2009 Dec; 32(12):2057-60. PubMed ID: 19952428
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.
Held JM; Britton DJ; Scott GK; Lee EL; Schilling B; Baldwin MA; Gibson BW; Benz CC
Mol Cancer Res; 2012 Aug; 10(8):1120-32. PubMed ID: 22669764
[TBL] [Abstract][Full Text] [Related]
20. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
